NCT01327235 - Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites | Biotech Hunter

Enrollment

336

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

July 31, 2014

Conditions

Malignant Pleural EffusionMalignant Ascites

Interventions

DRUG

Endostar

intrapleural injection 45 mg; intraperitoneal injection 60 mg, q3d ×3(d1、d4、d7), 3 times as one cycle, at most 2 cycles

DRUG

Cisplatin

cisplatin 40 mg, q3d ×3(d1、d4、d7), 3 times as one cycle, at most 2 cycles

Trial Locations (3)

The 81st Hospital of Chinese PLA, Nanjing

The Affiliated Hospital of Medical College, QingDao University, Qingdao

Fudan University Shanghai Cancer Center, Shanghai